Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Merck says osteoporosis drug clears phase II trial

Odanacatib on track for 2013 filing

European orphan drug applications up 30 per cent

But lower than expected generics applications see EMA reduce new marketing authorisation forecast

- PMLiVE

Indonesia breaks seven HIV, hepatitis drug patents

Merck & Co, GSK, Gilead, Abbott and BMS all effected

NHS’ Jim Easton reportedly joining Care UK

HSJ says he has resigned as director of transformation at NHS Commissioning Board

PRA picks Sean Leech to lead in Europe, Asia Pacific and Africa

His previous experience includes an eight-year spell with fellow CRO Icon

The evolving landscape of medical education, part four

Knowing the different types of learners will help you develop a more comprehensive education programme

Ogilvy APAC injects new creativity into its healthcare comms

Agency appoint BBDO’s Pete Smith as regional innovation and creative director

UK homecare growth faces potential challenge from HCP resistance

More effort needed to explain benefits to medical staff in hospitals, NCHA conference told

AZ’s MedImmune partners with global cancer institutes

Will research combinations of immunotherapies

- PMLiVE

Janssen unveils €30,000 prize fund for health tech innovation

Will look for 'transformational ideas' in homecare, adherence and personal health management

Novartis building

Gilenya cuts early relapse, brain loss in MS patients

Boosts prospects for oral drug as competitors emerge

Pharma must ’embrace the new reality’ and meet payers’ needs

This means capturing better health economic data during product development, says Takeda's Trevor Smith

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links